Your browser doesn't support javascript.
loading
Diagnostic accuracy of ureteroscopic biopsy in predicting stage and grade at final pathology in upper tract urothelial carcinoma: Systematic review and meta-analysis.
Subiela, José Daniel; Territo, Angelo; Mercadé, Asier; Balañà, Josep; Aumatell, Julia; Calderon, Julio; Gallioli, Andrea; González-Padilla, Daniel A; Gaya, Josep Maria; Palou, Joan; Breda, Alberto.
Afiliação
  • Subiela JD; Oncology Urology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Carrer de Cartagena 340-350, 08025, Barcelona, Spain. Electronic address: jdsubiela@fundacio-puigvert.es.
  • Territo A; Oncology Urology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Carrer de Cartagena 340-350, 08025, Barcelona, Spain. Electronic address: aterrito@fundacio-puigvert.es.
  • Mercadé A; Oncology Urology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Carrer de Cartagena 340-350, 08025, Barcelona, Spain. Electronic address: amercade@fundacio-puigvert.es.
  • Balañà J; Oncology Urology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Carrer de Cartagena 340-350, 08025, Barcelona, Spain. Electronic address: jbalana@fundacio-puigvert.es.
  • Aumatell J; Oncology Urology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Carrer de Cartagena 340-350, 08025, Barcelona, Spain. Electronic address: jaumatell@fundacio-puigvert.es.
  • Calderon J; Oncology Urology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Carrer de Cartagena 340-350, 08025, Barcelona, Spain. Electronic address: jcalderon@fundacio-puigvert.es.
  • Gallioli A; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Urology, Department of Clinical Sciences and Community Health, University of Milan, Via della Commenda, 10, 20122, Milan, Italy. Electronic address: andrea.gallioli@gmail.com.
  • González-Padilla DA; Department of Urology, Hospital 12 de Octubre, Av. de Córdoba, s/n, 28041, Madrid, Spain. Electronic address: daniel.mx@gmail.com.
  • Gaya JM; Oncology Urology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Carrer de Cartagena 340-350, 08025, Barcelona, Spain. Electronic address: jmgaya@fundacio-puigvert.es.
  • Palou J; Oncology Urology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Carrer de Cartagena 340-350, 08025, Barcelona, Spain. Electronic address: jpalou@fundacio-puigvert.es.
  • Breda A; Oncology Urology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Carrer de Cartagena 340-350, 08025, Barcelona, Spain. Electronic address: abreda@fundacio-puigvert.es.
Eur J Surg Oncol ; 46(11): 1989-1997, 2020 11.
Article em En | MEDLINE | ID: mdl-32674841
ABSTRACT

OBJECTIVE:

To assess the accuracy of ureteroscopic (URS) biopsies in predicting stage and grade at final pathology in upper tract urothelial carcinoma (UTUC). MATERIALS AND

METHODS:

The meta-analysis was performed in accordance with the PRISMA statement. Studies providing data on tumor stage and grade at URS biopsy and surgical specimens were included. The negative predictive value (NPV) implies concordance between the absence of subepithelial connective tissue invasion or the presence of low-grade tumors at URS biopsy and the absence of a muscle-invasive disease in the final pathology.

RESULTS:

A total of 23 studies were included (3547 patients). The stage-to-stage match between URS biopsy/final pathology showed a positive predictive value (PPV) for cT1+/muscle-invasive disease of 94% (95% CI 84%-100%) and a NPV for cTa-Tis/non-muscle-invasive disease of 60% (95% CI 52%-68%). The grade-to-grade match between URS biopsy/final pathology was 66% (95% CI 55%-77%) for low-grade (cLG/pLG) tumors and 97% (95% CI 94%-98%) for high-grade (cHG/pHG) tumors. The PPV for cHG/muscle-invasive disease was 60% (95% CI 54%-66%) and the NPV for cLG/non-muscle-invasive disease was 77% (95% CI 73%-82%). The undergrading and understaging rates were 32% (95%CI 25%-38%) and 46% (95% CI 38%-54%), respectively.

CONCLUSIONS:

There is a substantial correlation between tumor grade at URS biopsy and the final pathology. The identification of cHG tumors and subepithelial connective tissue invasion (cT1+) in URS biopsy showed a moderate and a strong correlation with invasive UTUC, respectively. Nevertheless, a certain risk of undergrading and understaging should be assumed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ureterais / Biópsia / Carcinoma de Células de Transição / Ureteroscopia / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Eur J Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ureterais / Biópsia / Carcinoma de Células de Transição / Ureteroscopia / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Eur J Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article